Press Release | Tue May 20, 2014 8:00am EDT

Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associated with Overall Survival Benefits In Advanced Prostate Cancer

* Reuters is not responsible for the content in this press release.